PTAB Reverses § 101 Rejection of Receptor-Derived Peptide Claims

PTAB Affirms §101 Rejection of Psilocybin Composition, Post-Appeal Prosecution Results in Granted Patent

PTAB Finds that Psilocybin Formulation Is Not a Product of Nature, Further Prosecution Leads to Issued Patent

PTAB Affirms §101 Rejection of Human Milk Product Claims

Patent Trial and Appeal Board Doubles Down on Natural Products Doctrine in Human Milk Case

PTAB Reverses §101 Rejection of Cannabis Composition Claims

Patent Trial and Appeal Board Finds That Cannabis Delivery System Is Not a Natural Product

PTAB Affirms § 101 Rejection of Synthetic Milk Sugar Mixture

The Patent Trial and Appeal Board recently affirmed the 35 U.S.C. § 101 rejection of patent claims for a mixture of three human milk oligosaccharides (HMOs), finding the mixture to be ineligible for patenting

PTAB Reverses §101 Rejection of Probiotic + Prebiotic Composition Claims

Patent Trial and Appeal Board Finds That Probiotic Formulation Is Not a Product of Nature

PTAB Reverses § 101 Rejection of Formulation Containing Component that Mimics Human Product

PTAB Finds That Base Oil + Essential Oil Formulation is Not a Natural Product

OTC MONOGRAPHS @ FDA | FDA

How to Fight Your Health Insurance Denial With an External Appeal — ProPublica

When a health insurer refuses to pay for your treatment, you may have the right to have the denial reviewed — and potentially overturned — by an independent provider. Here are six steps experts suggest to help you through the external appeal process.

Patent Eligibility of Nature Based Food Products

Nature-Based Food Products May Be Eligible for Patenting Under 35 U.S.C. § 101

Tachyum Defends TPU® Trademark from Infringement by Google TPU | Tachyum

Tachyum® today announced that it is beginning to take steps to defend the use of its registered TPU® trademark.

The FDA Sentinel Real World Evidence Data Enterprise ( RWE ‐ DE )

Purpose The US Food and Drug Administration's Sentinel Innovation Center aimed to establish a query-ready, quality-checked distributed data network containing electronic health records (EHRs) linked...

The FDA Sentinel Real World Evidence Data Enterprise ( RWE ‐ DE )

Purpose The US Food and Drug Administration's Sentinel Innovation Center aimed to establish a query-ready, quality-checked distributed data network containing electronic health records (EHRs) linked...

FDA approves first mRNA-based flu vaccine | CNN

The US Food and Drug Administration on Wednesday approved the United States’ first mRNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.

Pro Se Plaintiff Caught Hiding Prompt Injections In Court Filings; Responds By Hiding More

There have now been dozens of stories of bad lawyers using AI results in filings, most of which show up in the form of fake case citations. That’s old hat at this point. But how about prompt …

Companies Are Using Reddit to Manipulate ChatGPT and Google AI Search

Peptide companies have been doing AI-engine optimization by spamming the biohackers subreddit to manipulate ChatGPT and Google.

PubPeer - Efficacy of oral folinic acid supplementation in children wi... | Ioana A. Cristea | 13 comments

Over the last week, I have privately been in contact with several friends and collaborators over the *SINGLE* study that was cited by the FDA in supporting the label extension of leucovorin for autism spectrum disorders. https://lnkd.in/dHpfCt_9 https://lnkd.in/dYWbHXyY Given the enormous importance of this study, and the fact that the results look too good to be true and there are various signals I would have thought would have raised a sleuth eyebrow (for example, Table 1 where all categorical values in each group except for 1 differ by exactly one unit), I am very surprised that until now the only Pubpeer comments are by two MDs and by myself, pointing to some inconsistencies between tables and figures. https://lnkd.in/duFQDccr I have also formally asked the authors for the individual participant data. Perhaps given this is not some random wacky study about how much food can one eat in a fast-food or some obscure paper citing another obscure retracted paper, but the SINGLE study that now underpins the retrospective post-marketing approval of an entire treatment, the very large community of people who want to correct science ASAP particularly when findings have huge policy implications could join me in scrutinizing this study to make sure findings are reliable and that the data are correct and analyzed correctly. | 13 comments on LinkedIn